Opioids cross the placenta and should develop respiratory despair and psycho-physiologic outcomes in neonates. An opioid antagonist, for instance naloxone, needs to be accessible for reversal of opioid-induced respiratory depression within the neonate. OXYCONTIN is not advisable to be used in Female